GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » EPS (Basic)

Skystar Bio-Pharmaceutical Co (FRA:GNJC) EPS (Basic) : €1.01 (TTM As of Sep. 2014)


View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co EPS (Basic)?

Skystar Bio-Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Sep. 2014 was €0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2014 was €1.01.

Skystar Bio-Pharmaceutical Co's EPS (Diluted) for the three months ended in Sep. 2014 was €0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2014 was €1.00.

Skystar Bio-Pharmaceutical Co's EPS without NRI for the three months ended in Sep. 2014 was €0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2014 was 1.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Skystar Bio-Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co EPS (Basic) Chart

Skystar Bio-Pharmaceutical Co Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 1.50 1.44 0.63 1.01

Skystar Bio-Pharmaceutical Co Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.01 - - -

Skystar Bio-Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Skystar Bio-Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2013 is calculated as

Basic EPS (A: Dec. 2013 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(7.687-0)/7.652
=1.00

Skystar Bio-Pharmaceutical Co's Basic EPS for the quarter that ended in Sep. 2014 is calculated as

Basic EPS (Q: Sep. 2014 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3.809-0)/7.6048
=0.50

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Skystar Bio-Pharmaceutical Co  (FRA:GNJC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Skystar Bio-Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Traded in Other Exchanges
N/A
Address
No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN
Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines